- Home
- BIVI vs ATCX Comparison
BIVI vs ATCX Comparison
Compare BIVI & ATCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BIVI | ATCX |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4M | 13.2M |
| IPO Year | 2013 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BIVI | ATCX |
|---|---|---|
| Price | $1.58 | $1.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $5.26 | ★ $18.58 |
| AVG Volume (30 Days) | ★ 156.3K | 10.7K |
| Earning Date | 11-17-2026 | 03-16-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.83 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $873.07 |
| Revenue Next Year | N/A | $122.22 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.82 | $1.85 |
| 52 Week High | $3.79 | $14.01 |
Technical Indicators
Market Signals| Indicator | BIVI | ATCX |
|---|---|---|
| Relative Strength Index (RSI) | 51.21 | 29.24 |
| Support Level | $1.28 | N/A |
| Resistance Level | $1.52 | $3.86 |
| Average True Range (ATR) | 0.11 | 0.13 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 83.78 | 15.56 |
Price Performance
Historical ComparisonAbout BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies for the treatment of neurological and neurodegenerative disorders and liver disease. Its therapeutic areas include Alzheimer's, Parkinson's, Long COVID, Ascites, Longevity, and Epigenetics. In liver disease, its investigational drug candidate BIV201 (continuous infusion terlipressin) was granted FDA Fast Track status and FDA Orphan Drug designation for ascites due to all etiologies except cancer. BIV201 is being evaluated as a treatment option for patients suffering from life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism.
About ATCX Atlas Critical Minerals Corporation Common Stock
Atlas Critical Minerals Corp is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.